Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PROSTATE CANCER Latest News

6 HOURS AGO - Health Canal

A Must Read - Share

Diffusion Tensor MR Tractography Effective as Quantitative Tool, Treatment Marker Response

TORONTO —Preliminary results of a study of patients with prostate cancer show that MR tractography may be a reliable quantitative imaging biomarker to assess prostate cancer treatment response to androgen deprivation and radiation therapy, according to a team of researchers at Brigham and Women's Hospital and Massachusetts General Hospital in Boston. Quantitative evaluation shows higher tract densities after androgen deprivation ...

Tags: Diffusion Tensor MR Tractography Effective as Quantitative Tool, Treatment Marker Response,  Prostate Cancer Latest News

APR 26, 2015 - MedicineNet

A Must Read - Share

Dogs Find Prostate Cancer by Smell

Title: Dogs Find Prostate Cancer by SmellCategory: Health NewsCreated: 4/21/2015 12:00:00 AMLast Editorial Review: 4/21/2015 12:00:00 AM

Tags: Dogs Find Prostate Cancer by Smell,  Prostate Cancer Latest News

APR 23, 2015 - Huffington Post

A Must Read - Share

U.S. Cancer Survival Rates Are Improving

By Andrew M. Seaman (Reuters Health) - The proportion of people surviving years after a cancer diagnosis is improving, according to a new analysis. For men and women ages 50 to 64, who were diagnosed in 2005 to 2009 with a variety of cancer types, the risk of dying from those cancers within five years of diagnosis was 39 to ...

Tags: U.S. Cancer Survival Rates Are Improving,  Prostate Cancer Latest News

APR 22, 2015 - Health Canal

A Must Read - Share

Trial shows benefit of ‘BRCA-targeting’ drug in prostate cancer

Men with prostate cancer benefit from treatment with the pioneering drug olaparib – the first cancer drug to target inherited mutations – according to the results of a major trial presented today.

Tags: Trial shows benefit of ‘BRCA-targeting’ drug in prostate cancer,  Prostate Cancer Latest News

APR 21, 2015 - Yahoo! News

A Must Read - Share

AstraZeneca drug Lynparza shows promise in prostate cancer trial

AstraZeneca's recently approved ovarian cancer drug Lynparza, or olaparib, can also help men with prostate cancer, according to new clinical trial results on Tuesday. The news is the latest boost to the British company's cancer drug pipeline, which formed a central plank of its defense against a $118 billion takeover attempt by Pfizer last year. AstraZeneca has flagged olaparib as ...

Tags: AstraZeneca drug Lynparza shows promise in prostate cancer trial,  Prostate Cancer Latest News